Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine
Adjuvant developed with NIH funding enhances the efficacy of India’s COVID-19 vaccine. The adjuvant used in the COVID-19 COVAXIN vaccine,...
Adjuvant developed with NIH funding enhances the efficacy of India’s COVID-19 vaccine. The adjuvant used in the COVID-19 COVAXIN vaccine,...